Progress in Cancer Control Leads to Significant Number of Cancer Deaths Avoided in Canada.


Journal

JNCI cancer spectrum
ISSN: 2515-5091
Titre abrégé: JNCI Cancer Spectr
Pays: England
ID NLM: 101721827

Informations de publication

Date de publication:
12 Dec 2023
Historique:
received: 03 09 2023
revised: 26 10 2023
accepted: 04 12 2023
medline: 12 12 2023
pubmed: 12 12 2023
entrez: 12 12 2023
Statut: aheadofprint

Résumé

It is currently not known how many more cancer deaths would have occurred among Canadians if cancer mortality rates were unchanged due to various modern human interventions. The objective of this study was to estimate the number of cancer deaths that have been avoided in Canada since the age-standardized cancer mortality rate peaked in 1988. We applied the age-specific cancer mortality rates from 1988 to the Canadian population for all subsequent years to estimate the number of expected deaths. Avoided cancer deaths were estimated as the difference between the observed and expected number of cancer deaths for each year. Since 1988, there have been 372,584 (SMR=0.77) and 120,045 (SMR=0.90) avoided cancer deaths in males and females, respectively (492,629 total). There have been nearly half a million cancer deaths avoided in Canada since the overall cancer mortality rate peaked. This demonstrates the exceptional progress made in modern cancer control in Canada.

Identifiants

pubmed: 38085245
pii: 7470749
doi: 10.1093/jncics/pkad105
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press.

Auteurs

Matthew T Warkentin (MT)

Department of Oncology, Cumming School of Medicine, Univeristy of Calgary, Calgary, AB, Canada.

Yibing Ruan (Y)

Department of Oncology, Cumming School of Medicine, Univeristy of Calgary, Calgary, AB, Canada.

Larry F Ellison (LF)

Centre for Population Health Data, Statistics Canada, Ottawa, ON, Canada.

Jean-Michel Billette (JM)

Centre for Population Health Data, Statistics Canada, Ottawa, ON, Canada.

Alain Demers (A)

Adult Chronic Diseases and Conditions Division, Public Health Agency of Canada, Ottawa, ON, Canada.

Fei-Fei Liu (FF)

Institute of Cancer Research, Canadian Institutes of Health Research, Ottawa, ON, Canada.

Darren R Brenner (DR)

Department of Oncology, Cumming School of Medicine, Univeristy of Calgary, Calgary, AB, Canada.

Classifications MeSH